- Datum03.11.2026
- Uhrzeit12:00 - 13:00 Uhr
- Veranstalter
stock3
Kein Moderator verfügbar
Insulet Corporation Chart inkl. Chartanalyse
Charts analysieren
wie die Profis?
Nutze unser Profi-Charting-Tool für Deine eigenen Analysen
Chart analysieren
Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| Nasdaq | VK | |||||
| L&S | VK | |||||
| Tradegate BSX | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
0,48 %
Intraday
6,50 %
1 Woche
1,50 %
1 Monat
-49,82 %
Seit Jahresbeginn
-56,64 %
1 Jahr
-1,44 %
3 Jahre
-52,98 %
5 Jahre
255,89 %
10 Jahre
Passender Service zu Insulet Corporation
Webinar zu Insulet Corporation
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)126,400-354,880
- Jahrestief / Hoch ($)126,400-299,795
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Werbung
Schnellsuche von
Im Durchschnitt erleiden 7 von 10 Kleinanlegern Verluste beim Handel mit Turbo-Zertifikaten. Turbo-Zertifikate sind hoch risikoreiche Produkte und nicht für langfristige Anlagestrategien geeignet.
Termine von Insulet Corporation
- Nov4Insulet CorporationQ3 2026 Earnings Release
- Feb25Insulet CorporationQ4 2026 Earnings Release
- Mai6Insulet CorporationQ1 2027 Earnings Release
Beschreibung
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
